Genscript Biotech Corporation (FRA:G51)
1.342
-0.005 (-0.33%)
At close: Jan 30, 2026
3.99% (1Y)
| Market Cap | 3.03B +20.9% |
| Revenue (ttm) | 705.13M +63.2% |
| Net Income | 2.65B |
| EPS | 1.20 |
| Shares Out | n/a |
| PE Ratio | 1.14 |
| Forward PE | 33.62 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 293 |
| Open | 1.342 |
| Previous Close | 1.346 |
| Day's Range | 1.342 - 1.342 |
| 52-Week Range | 1.119 - 2.042 |
| Beta | n/a |
| RSI | 35.59 |
| Earnings Date | Mar 10, 2026 |